- Home
- ACTG vs NVCT Comparison
ACTG vs NVCT Comparison
Compare ACTG & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTG
- NVCT
- Stock Information
- Founded
- ACTG 1993
- NVCT 2020
- Country
- ACTG United States
- NVCT United States
- Employees
- ACTG N/A
- NVCT N/A
- Industry
- ACTG Multi-Sector Companies
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- ACTG Miscellaneous
- NVCT Health Care
- Exchange
- ACTG Nasdaq
- NVCT Nasdaq
- Market Cap
- ACTG 289.2M
- NVCT 249.1M
- IPO Year
- ACTG 1996
- NVCT 2022
- Fundamental
- Price
- ACTG $3.77
- NVCT $8.99
- Analyst Decision
- ACTG
- NVCT Strong Buy
- Analyst Count
- ACTG 0
- NVCT 3
- Target Price
- ACTG N/A
- NVCT $17.00
- AVG Volume (30 Days)
- ACTG 285.6K
- NVCT 157.3K
- Earning Date
- ACTG 05-08-2025
- NVCT 05-06-2025
- Dividend Yield
- ACTG N/A
- NVCT N/A
- EPS Growth
- ACTG N/A
- NVCT N/A
- EPS
- ACTG N/A
- NVCT N/A
- Revenue
- ACTG $222,414,000.00
- NVCT N/A
- Revenue This Year
- ACTG $86.80
- NVCT N/A
- Revenue Next Year
- ACTG N/A
- NVCT N/A
- P/E Ratio
- ACTG N/A
- NVCT N/A
- Revenue Growth
- ACTG 65.22
- NVCT N/A
- 52 Week Low
- ACTG $2.70
- NVCT $4.44
- 52 Week High
- ACTG $5.74
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- ACTG 72.30
- NVCT 47.46
- Support Level
- ACTG $2.99
- NVCT $8.01
- Resistance Level
- ACTG $3.21
- NVCT $9.62
- Average True Range (ATR)
- ACTG 0.14
- NVCT 1.04
- MACD
- ACTG 0.09
- NVCT -0.16
- Stochastic Oscillator
- ACTG 94.57
- NVCT 27.96
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.